The stocks to follow tomorrow on the Paris Stock Exchange – Wednesday January 18, 2023 – 01/17/2023 at 6:30 p.m.

(AOF) –


Catering International Services, a specialist in remote sites in hostile environments, has published its turnover for the fourth quarter.

Drone Volt

The drone specialist will announce its turnover for the fourth quarter.


“In a particularly difficult context for the distribution sector with increased pressure on household purchasing power which notably impacted this key end of the year for the Group”, Fnac Darty announces an estimate of its sales and results for the 2022 financial year. Free cash flow from operations was negative at €30 million, impacted by a drop in sales in December and by the negative effects of the working capital requirement. Free cash flow from operations amounted to 170 million euros in 2021.

Forsee Power

Forsee Power, expert in smart battery systems for sustainable electromobility, announces the appointment of Jean-Yves Quentel as Administrative and Financial Director. Aged 53, this Essec graduate has held the position of general manager or financial director in high-growth high-tech companies since 2010. He began his career in consulting and investment in technological venture capital in France and the United States in funds such as Atlas Venture, Europatweb (Groupe Arnault), and Logispring.


In 2022, Kalray recorded record consolidated revenue of €16.4 million compared to €1.5 million at December 31, 2021 (+1,025%). Its combined revenue (taking into account Arcapix over one year) also reached a historic level of €22.5 million as of December 31, 2022, above the announced target of €20 million.

Pierre & Holidays

Pierre & Vacances-Center Parcs publishes revenue for the 1st quarter of the 2022/2023 financial year at 351.8 million euros, compared to 314.2 million euros in the 1st quarter of 2021/2022. “Despite the current macro-economic tensions, the turnover of tourism activities showed sustained momentum with growth of 19.4% compared to the first quarter of 2021/2022” commented the group.


The biopharmaceutical company specializing in neurological diseases and a pioneer in the development of drug candidates acting on the interaction between neurons and glial cells will publish its fourth quarter sales.


The laboratory specializing in animal health will reveal its turnover for the fourth quarter.


The pharmaceutical laboratory dedicated to animal health will announce its turnover for the fourth quarter.


Leave a Comment

Your email address will not be published. Required fields are marked *